Khaled Adl
Madinat An Nasr, C 11884, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 75 publications
Design, synthesis, molecular docking, ADMET and anticancer evaluation of novel pyridine/thiazole hybrids as dual VEGFR-2 and EGFR kinase inhibitors.
Journal: Bioorganic chemistry
Published: July 24, 2026
Fourth-generation allosteric EGFR inhibitors: Structure-based scaffold analysis and SAR exploration.
Fourth-generation allosteric EGFR inhibitors: Structure-based scaffold analysis and SAR exploration.
Journal: Bioorganic chemistry
Published: March 30, 2026
Pyrazolo[3,4-d]pyrimidine derivatives as VEGFR-2 and EGFRT790M dual inhibitors: design, docking, ADMET, synthesis and anticancer evaluations.
Journal: RSC advances
Published: January 02, 2026
Pyrazole/pyrimidine derivatives endowed with azobenzenes as dual EGFRT790M and VEGFR-2 inhibitors: anticancer, docking, synthesis, design and ADMET assessments.
Journal: RSC advances
Published: November 20, 2025
Antibiofilm and antibacterial effects of Nigella sativa extract against Streptococcus mutans predicting the role of fatty acids composition: in vitro, CLSM and in silico studies.
Journal: Biomaterial investigations in dentistry
Published: August 27, 2025
Chitosan/polyacrylic acid nanogel-mediated delivery system for cancer treatment: Design, synthesis, ADMET, docking of thiazole derivatives as dual inhibitors of VEGFR-2 and EGFRT790M.
Journal: Bioorganic chemistry
Published: August 19, 2025
Synthesis of 4-chloro-N'-(2-cyanoacetyl)benzohydrazide derivatives, cytotoxicity, VEGFR-2/EGFRT790M bioassays and in silico docking/ADMET studies.
Journal: Bioorganic chemistry
Published: July 15, 2025
ADMET, docking, anticancer evaluations, design and synthesis of pyrazolo[1,5-a]pyrimidines substituted with furan and phenyldiazene as dual EGFRT790M and VEGFR-2 inhibitors.
Journal: Bioorganic chemistry
Published: May 30, 2025
A two-decade overview of oxadiazole derivatives as promising anticancer agents.
Journal: RSC advances
Published: May 26, 2025
Nano-carrier, design, synthesis, in silico ADMET, anti-proliferative assessments and docking of [1,2,4]triazolo[4,3-a]quinoxalines as Topo-II inhibitors and DNA intercalators.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: February 08, 2025
Semi-synthesis and biological activities of heterocyclic compounds containing camphor.
Journal: RSC advances
Published: January 20, 2025
Dual VEGFR-2 and EGFRT790M inhibitors of phenyldiazenes: anticancer evaluations, ADMET, docking, design and synthesis.
Journal: Future medicinal chemistry
Published: January 17, 2025
Last Updated: 09/26/2026